SCHEMBL21499355

SCHEMBL21499355

COc1cc2c(cc1NC(=O)Cc1cccs1)CCCCN2

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.58
KMT2A Q03164 10/20 0.58
POLB P06746 7/20 0.58
L3MBTL1 Q9Y468 6/20 0.58
USP2 O75604 2/20 0.58
TDP1 Q9NUW8 4/20 0.58
ALDH1A1 P00352 4/20 0.58
RECQL P46063 4/20 0.58
CTDSP1 Q9GZU7 3/20 0.58
MAPT P10636 3/20 0.58
BLM P54132 3/20 0.58
KDM4E B2RXH2 2/20 0.58
THRB P10828 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.56
LMNA P02545 2/20 0.50
GAA P10253 1/20 0.50
ATM Q13315 1/20 0.47
MAPK8 P45983 1/20 0.47
MAPK9 P45984 1/20 0.47
MAPK10 P53779 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21468498 0.87 MEN1 (0.65) MEN1KMT2APOLBL3MBTL1USP2
SCHEMBL21499309 0.79 DHODH (0.57) MEN1KMT2ATDP1ALDH1A1MAPT
SCHEMBL21499368 0.77 ALDH1A1 (0.59) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL21499362 0.74 DHODH (0.54) MEN1KMT2ATDP1ALDH1A1MAPT
SCHEMBL21499314 0.74 MAPT (0.56) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL21499312 0.74 MAPT (0.58) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL21499328 0.73 MAPT (0.61) MEN1KMT2ATDP1ALDH1A1MAPT
SCHEMBL21499366 0.73 TSHR (0.46) MEN1KMT2AUSP2ALDH1A1MAPT
SCHEMBL21499358 0.73 MAPT (0.57) MEN1KMT2AUSP2ALDH1A1MAPT
SCHEMBL21499332 0.73 LMNA (0.58) MEN1KMT2AALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450263-B2 Benzo annulenes as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2019-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10450263-B2 Benzo annulenes as antiviral agents MAVS, ZC3HAV1, GABBR1 MEN1 2018/4885KMT2A 3171/4885POLB 2834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.